Active ingredientPimobendanCat. No. P-P114-001CAS 74150-27-9Family · Pharmaceutical analytical standards
Pimobendan
An inodilator that strengthens heart contraction by sensitising it to calcium and widens blood vessels by inhibiting phosphodiesterase 3: patented around 1980, it is now used mainly in dogs with heart failure. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Around the world it is known almost only as a veterinary medicine, but in Japan it has also been approved for use in humans.
Go to the active ingredient →Active ingredientPimobendanCat. No. P-P114-001CAS 74150-27-9
Pharmacopoeial impurityPimobendan EP Impurity ACat. No. P-P114-002CAS 2138391-23-6
Pharmacopoeial impurityPimobendan EP Impurity BCat. No. P-P114-003CAS 74149-74-9
Isotopically labelledPimobendan-13C-d3Cat. No. P-P114-004
ImpurityPimobendan Impurity 1Cat. No. P-P114-005CAS 74150-02-0
ImpurityPimobendan Impurity 2Cat. No. P-P114-007CAS 77469-62-6
ImpurityPimobendan Impurity 3Cat. No. P-P114-008No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substancePimobendan CRSEDQM code Y0000525Family PimobendanNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.